Abstract

Prion diseases are sub-acute neurodegenerative diseases that affect humans and some domestic and free-ranging animals. Infectious prion agents are considered to comprise solely of abnormally folded isoforms of the cellular prion protein known as PrPSc. Pathology during prion disease is restricted to the central nervous system where it causes extensive neurodegeneration and ultimately leads to the death of the host. The first half of this review provides a thorough account of our understanding of the various ways in which PrPSc prions may spread between individuals within a population, both horizontally and vertically. Many natural prion diseases are acquired peripherally, such as by oral exposure, lesions to skin or mucous membranes, and possibly also via the nasal cavity. Following peripheral exposure, some prions accumulate to high levels within the secondary lymphoid organs as they make their journey from the site of infection to the brain, a process termed neuroinvasion. The replication of PrPSc prions within secondary lymphoid organs is important for their efficient spread to the brain. The second half of this review describes the key tissues, cells and molecules which are involved in the propagation of PrPSc prions from peripheral sites of exposure (such as the lumen of the intestine) to the brain. This section also considers how additional factors such as inflammation and aging might influence prion disease susceptibility.

Highlights

  • The prion diseases are a unique group of sub-acute neurodegenerative diseases that affect humans and certain domestic and free-ranging animals

  • The pathology caused during prion disease is considered to be restricted almost entirely to the central nervous system (CNS), where it causes extensive neurodegeneration which leads to death

  • To reduce the risk of potential transmission of variant Creutzfeldt-Jakob disease (CJD) by blood transfusion the UK implemented universal leucodepletion in 1999. This rationale was based on observations that PrPSc could be detected in lymphoid tissues of vCJD patients [66,67] implying that cells such as lymphocytes might potentially contaminate the blood-stream with prions

Read more

Summary

Introduction

The prion diseases are a unique group of sub-acute neurodegenerative diseases that affect humans and certain domestic and free-ranging animals. The characteristic histopathological features of CNS prion diseases include vacuolation in the brain (spongiform pathology), neurodegeneraton, microgliosis, astrocytosis, and abnormal accumulations of PrPSc. Several different forms of prion diseases have been described: spontaneous, genetic, or acquired through various routes of exposure (Table 1). Examples of vertical prion transmission between an infected mother to the developing fetus or offspring have been reported In addition to their important health and economic impacts to livestock industries, some prion disease have zoonotic potential. Sporadic CJD (sCJD), in contrast, typically affects elderly individuals and has an unknown etiology and incidence of approximately 1/million population per annum throughout the world Whether this prion disease is acquired is uncertain, but a study using experimental mice has proposed that sheep scrapie prions may have zoonotic potential and cause a disease in the recipients with characteristics identical to sCJD [3]. This section describes how additional factors such as inflammation and aging can influence prion disease susceptibility

Transmission of PrPSc Prions between Host Species
Horizontal Transmission
Prions Can Be Shed into the Environment and Can Remain Infectious
Nasal Cavity Is a Potential Portal for Prion Entry
Lesions to Skin and Mucous Membranes
Accidental Iatrogenic Transmission in Humans
Vertical Transmission
Prions and the Prion Protein
The Cellular Dissemination of PrPSc Prions within the Host
Prions Cross the Gut Epithelium via M Cells
Conventional Dendritic Cells Aid the Delivery of Prions to SLO
Macrophages Can Phagocytose and Destroy Prions
Cell Free
B Cells Indirectly Support Prion Replication in SLO
Follicular Dendritic Cells Retain and Replicate Prions
FDC Acquire Prions as Complement-Opsonized Complexes
Conventional DC Can Shuttle Prions towards FDC
FDC-Independent Prion Accumulation and Neuroinvasion
Prion Infections Cause Limited Pathology in SLO
B Cells Aid the Spread of Prions between SLO
Effects of Host Age on Prion Disease Pathogenesis and Susceptibility
Opportunities for Prophylactic and Therapeutic Intervention
PrPSc as a Therapeutic Target
Quinacrine
Pentosan Polysulphate
Tetracyclic Antibiotics
Prions as Anti-Prions
Targeting Prion-Induced Neurodegeneration
Immunization
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.